Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Injectable peptide formulations often include antioxidants to combat oxidative degradation, but these protective agents have limited capacity
This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist
Red flags to avoid Stay away from : Pre-mixed liquid BPC-157 (degrades quickly) Suppliers without testing documentation Prices too good to be true ($10-15 per vial = fake) Vague product descriptions No batch numbers Quality matters : Poor quality BPC-157 won't work
In experimental models of spinal cord damage in rats, early post-injury administration of the peptide was associated with marked improvements in neurological function
Route: Intramuscular (IM) or subcutaneous (SubQ)
US$ 26.65
US$ 24.07
US$ 27.31
US$ 23.33
US$ 20.23
US$ 29.45
US$ 28.65
US$ 26.20
US$ 29.70
US$ 26.21
US$ 20.76
US$ 29.22